|
|
|
Volumn 2, Issue 7, 2004, Pages 441-446
|
|
The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMINOID;
BLOOD CLOTTING FACTOR 8;
F8 PROTEIN, HUMAN;
RECOMBINANT PROTEIN;
ADOLESCENT;
ADULT;
AGED;
ANIMAL;
ARTICLE;
BLOOD CLOTTING TEST;
BLOODBORNE BACTERIUM;
CELL LINE;
CHEMISTRY;
CHILD;
CHO CELL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CRICETULUS;
DRUG CONTAMINATION;
ECONOMICS;
GENETIC TRANSFECTION;
GENETICS;
HAMSTER;
HEMOPHILIA A;
HUMAN;
INFANT;
INFECTION CONTROL;
ISOLATION AND PURIFICATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTICENTER STUDY;
PRESCHOOL CHILD;
STANDARD;
SYRIAN HAMSTER;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ALBUMINS;
ANIMALS;
BLOOD COAGULATION TESTS;
BLOOD-BORNE PATHOGENS;
CELL LINE;
CELL LINE, TRANSFORMED;
CHILD;
CHILD, PRESCHOOL;
CHO CELLS;
CLINICAL TRIALS;
CRICETINAE;
CRICETULUS;
DRUG CONTAMINATION;
FACTOR VIII;
HEMOPHILIA A;
HUMANS;
INFANT;
INFECTION CONTROL;
MALE;
MESOCRICETUS;
MIDDLE AGED;
MULTICENTER STUDIES;
RECOMBINANT PROTEINS;
TRANSFECTION;
TREATMENT OUTCOME;
|
|
EID: 14344266902
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
